502
Views
30
CrossRef citations to date
0
Altmetric
Review

Cardiac dysautonomia in depression – heart rate variability biofeedback as a potential add-on therapy

, , , , , & show all
Pages 1287-1310 | Published online: 17 May 2019

References

  • Lépine J-P, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3–7. doi:10.2147/NDT.S1961721750622
  • Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000;157(12):1925–1932. doi:10.1176/appi.ajp.157.12.192511097952
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013.
  • Tolentino JC, Schmidt SL. DSM-5 criteria and depression severity: implications for clinical practice. Front Psychiatry. 2018;9:450. doi:10.3389/fpsyt.2018.0045030333763
  • Roehrig C. Mental disorders top the list of the most costly conditions in the United States: $201 billion. Health Aff. 2016;35(6):1130–1135. doi:10.1377/hlthaff.2015.1659
  • Trogdon JG, Murphy LB, Khavjou OA, et al. Costs of chronic diseases at the state level: the chronic disease cost calculator. Prev Chronic Dis. 2015;12:E140. doi:10.5888/pcd12.15013126334712
  • Greenberg PE, Fournier A-A, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155–162. doi:10.4088/JCP.14m0929825742202
  • Sobocki P, Jönsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9(2):87–98. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17007486. Accessed September 13, 2018.17007486
  • Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349(9063):1436–1442. doi:10.1016/S0140-6736(96)07495-89164317
  • Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Samet J, ed. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.003044217132052
  • Licinio J, Yildiz B, Wong M-L. Depression and cardiovascular disease: co-occurrence or shared genetic substrates? Mol Psychiatry. 2002;7(10):1031–1032. doi:10.1038/sj.mp.400129312476313
  • Quintana DS, Alvares GA, Heathers JAJ. Guidelines for Reporting Articles on Psychiatry and Heart rate variability (GRAPH): recommendations to advance research communication. Transl Psychiatry. 2016;6(5):e803–e803. doi:10.1038/tp.2016.7327163204
  • Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the american heart association. Circulation. 2014;129(12):1350–1369. doi:10.1161/CIR.000000000000001924566200
  • Kano O, Ikeda K, Cridebring D, Takazawa T, Yoshii Y, Iwasaki Y. Neurobiology of depression and anxiety in Parkinson’s disease. Parkinsons Dis. 2011;2011:143547. doi:10.4061/2011/14354721687804
  • Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323–331. doi:10.1038/nrneurol.2011.6021537355
  • Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, Maes M. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut–brain pathways. CNS Spectr. 2016;21(02):184–198. doi:10.1017/S109285291500044926307347
  • Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54(3):248–261. doi:10.1016/S0006-3223(03)00568-712893101
  • Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58(3):221–227. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11231827. Accessed September 21, 2018.11231827
  • Glassman AH. Depression and cardiovascular comorbidity. Dialogues Clin Neurosci. 2007;9(1):9–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17506222. Accessed September 21, 2018.17506222
  • Frasure-Smith N, Lesperance F. Depression and cardiac risk: present status and future directions. Heart. 2010;96(3):173–176. doi:10.1136/hrt.2009.18695719861300
  • Zellweger MJ, Osterwalder RH, Langewitz W, Pfisterer ME. Coronary artery disease and depression. Eur Heart J. 2004;25(1):3–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14683736. Accessed October 12, 2018.14683736
  • Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med. 66(3):305–315. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15184688. Accessed October 12, 2018.
  • Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93(11):1976–1980. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8640971. Accessed September 21, 2018.8640971
  • Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001. doi:10.1161/hc4201.097834
  • Freedland KE, Carney RM, Rich MW. Effect of depression on prognosis in heart failure. Heart Fail Clin. 2011;7(1):11–21. doi:10.1016/j.hfc.2010.08.00321109204
  • Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence. J Hypertens. 2012;30(5):842–851. doi:10.1097/HJH.0b013e32835080b722343537
  • Dhar AK, Barton DA. Depression and the link with cardiovascular disease. Front Psychiatry. 2016;7:33. doi:10.3389/fpsyt.2016.0003327047396
  • Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study. Arch Intern Med. 2005;165(21):2508–2513. doi:10.1001/archinte.165.21.250816314548
  • Kronish IM, Rieckmann N, Halm EA, et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med. 2006;21(11):1178–1183. doi:10.1111/j.1525-1497.2006.00586.x16899061
  • Stapelberg NJC, Neumann DL, Shum DHK, McConnell H, Hamilton-Craig I. A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. Aust New Zeal J Psychiatry. 2011;45(5):351–369. doi:10.3109/00048674.2011.570427
  • Meijer A, Conradi HJ, Bos EH, et al. Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis. Br J Psychiatry. 2013;203(02):90–102. doi:10.1192/bjp.bp.112.11119523908341
  • Fiedorowicz JG, He J, Merikangas KR. The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample. J Psychosom Res. 2011;70(2):145–154. doi:10.1016/j.jpsychores.2010.07.01021262417
  • Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry. 1998;155(1):4–11. doi:10.1176/ajp.155.1.49433332
  • Fiedorowicz JG. Depression and cardiovascular disease: an update on how course of illness may influence risk. Curr Psychiatry Rep. 2014;16(10):492. doi:10.1007/s11920-014-0492-625163592
  • Abboud FM, Harwani SC, Chapleau MW. Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Hypertens (Dallas, Tex 1979). 2012;59(4):755–762. doi:10.1161/HYPERTENSIONAHA.111.186833
  • Pizzi C, Manzoli L, Mancini S, Costa GM. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J. 2008;29(9):1110–1117. doi:10.1093/eurheartj/ehn13718400765
  • Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171–186. doi:10.1097/PSY.0b013e3181907c1b19188531
  • Fontoura PC, Pinto VLM, Matsuura C, et al. Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: a potential role for platelet dysfunction. Psychosom Med. 2012;74(8):873–877. doi:10.1097/PSY.0b013e318268946023023680
  • Thayer JF, Lane RD. A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord. 2000;61(3):201–216. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11163422. Accessed October 10, 2018.11163422
  • Damasio AR, Grabowski TJ, Bechara A, et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci. 2000;3(10):1049–1056. doi:10.1038/7987111017179
  • Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993;68(10):988–1001. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8412366. Accessed October 13, 2018.8412366
  • Rauch SL, Shin LM, Phelps EA. neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research – past, present, and future. Biol Psychiatry. 2006;60(4):376–382. doi:10.1016/j.biopsych.2006.06.00416919525
  • Quirk GJ, Garcia R, González-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry. 2006;60(4):337–343. doi:10.1016/j.biopsych.2006.03.01016712801
  • Thayer JF, Hansen AL, Saus-Rose E, Johnsen BH. Heart rate variability, prefrontal neural function, and cognitive performance: the neurovisceral integration perspective on self-regulation, adaptation, and health. Ann Behav Med. 2009;37(2):141–153. doi:10.1007/s12160-009-9101-z19424767
  • Motzkin JC, Philippi CL, Wolf RC, Baskaya MK, Koenigs M. Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans. Biol Psychiatry. 2015;77(3):276–284. doi:10.1016/j.biopsych.2014.02.01424673881
  • Toyoda H, Li X-Y, Wu L-J, et al. Interplay of amygdala and cingulate plasticity in emotional fear. Neural Plast. 2011;2011:813749. doi:10.1155/2011/81374921912749
  • Hamilton JP, Siemer M, Gotlib IH. Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry. 2008;13(11):993–1000. doi:10.1038/mp.2008.5718504424
  • Drevets WC, Price JL, Bardgett ME, Reich T, Todd RD, Raichle ME. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav. 2002;71(3):431–447. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11830178. Accessed October 20, 2018.11830178
  • Critchley HD, Wiens S, Rotshtein P, Öhman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci. 2004;7(2):189–195. doi:10.1038/nn117614730305
  • Sliz D, Hayley S. Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research. Front Hum Neurosci. 2012;6:323. doi:10.3389/fnhum.2012.0032323227005
  • Lee B-T, Cho SW, Khang HS, et al. The neural substrates of affective processing toward positive and negative affective pictures in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(7):1487–1492. doi:10.1016/j.pnpbp.2007.06.03017688985
  • Nagai M, Hoshide S, Kario K. The insular cortex and cardiovascular system: a new insight into the brain-heart axis. J Am Soc Hypertens. 2010;4(4):174–182. doi:10.1016/j.jash.2010.05.00120655502
  • Kollai M, Jokkel G, Bonyhay I, Tomcsanyi J, Naszlady A. Relation between baroreflex sensitivity and cardiac vagal tone in humans. Am J Physiol Circ Physiol. 1994;266(1):H21–H27. doi:10.1152/ajpheart.1994.266.1.H21
  • Shaffer F, McCraty R, Zerr CL. A healthy heart is not a metronome: an integrative review of the heart’s anatomy and heart rate variability. Front Psychol. 2014;5:1040. doi:10.3389/fpsyg.2014.0104025324790
  • Lehrer P, Eddie D. Dynamic processes in regulation and some implications for biofeedback and biobehavioral interventions. Appl Psychophysiol Biofeedback. 2013;38(2):143–155. doi:10.1007/s10484-013-9217-623572244
  • Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043–1065. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8598068. Accessed October 14, 2018.8598068
  • Goldberger JJ, Challapalli S, Tung R, Parker MA, Kadish AH. Relationship of heart rate variability to parasympathetic effect. Circulation. 2001;103(15):1977–1983. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11306527. Accessed October 14, 2018.11306527
  • Reynard A, Gevirtz R, Berlow R, Brown M, Boutelle K. Heart rate variability as a marker of self-regulation. Appl Psychophysiol Biofeedback. 2011;36(3):209–215. doi:10.1007/s10484-011-9162-121739294
  • Appelhans BM, Luecken LJ. Heart rate variability as an index of regulated emotional responding. Rev Gen Psychol. 2006;10(3):229–240. doi:10.1037/1089-2680.10.3.229
  • An E, Nolty A, Rensberger J, Hennig N, Amano S, Buckwalter J. B-65Heart rate variability as an index of stress resilience. Arch Clin Neuropsychol. 2016;31(6):637.3–637. doi:10.1093/arclin/acw043.140
  • Critchley HD, Garfinkel SN. Interactions between visceral afferent signaling and stimulus processing. Front Neurosci. 2015;9:286. doi:10.3389/fnins.2015.0028626379481
  • Critchley HD, Harrison NA. Visceral influences on brain and behavior. Neuron. 2013;77(4):624–638. doi:10.1016/j.neuron.2013.02.00823439117
  • McIntyre D, Kavussanu M, Ring C. Effects of arterial and cardiopulmonary baroreceptor activation on the upper limb nociceptive flexion reflex and electrocutaneous pain in humans. Pain. 2008;137(3):550–555. doi:10.1016/j.pain.2007.10.01818037241
  • Edwards L, McIntyre D, Carroll D, Ring C, Martin U. The human nociceptive flexion reflex threshold is higher during systole than diastole. Psychophysiology. 2002;39(5):678–681. 10.1017.S004857720201177012236336
  • Gray MA, Beacher FD, Minati L, et al. Emotional appraisal is influenced by cardiac afferent information. Emotion. 2012;12(1):180–191. doi:10.1037/a002508321988743
  • Garfinkel SN, Minati L, Gray MA, Seth AK, Dolan RJ, Critchley HD. Fear from the heart: sensitivity to fear stimuli depends on individual heartbeats. J Neurosci. 2014;34(19):6573–6582. doi:10.1523/JNEUROSCI.3507-13.201424806682
  • Usui H, Nishida Y. The very low-frequency band of heart rate variability represents the slow recovery component after a mental stress task. PLoS One. 2017;12(8):e0182611. doi:10.1371/journal.pone.018261128806776
  • Bertinieri G, Di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G. Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol Circ Physiol. 1988;254(2):H377–H383. doi:10.1152/ajpheart.1988.254.2.H377
  • La Rovere MT, Pinna GD, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol. 2008;13(2):191–207. doi:10.1111/j.1542-474X.2008.00219.x18426445
  • Maestri R, Raczak G, Danilowicz-Szymanowicz L, et al. Reliability of heart rate variability measurements in patients with a history of myocardial infarction. Clin Sci. 2010;118:195–201. doi:10.1042/CS20090183
  • Schwartz PJ, Billman GE, Stone HL. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation. 1984;69(4):790–800. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6697463. Accessed October 14, 2018.6697463
  • Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59(4):256–262. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3812275. Accessed October 14, 2018.3812275
  • Singh JP, Larson MG, Tsuji H, Evans JC, O’Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the framingham heart study. Hypertens (Dallas, Tex 1979). 1998;32(2):293–297. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9719057. Accessed October 14, 2018.
  • Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98(15):1510–1516. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9769304. Accessed October 14, 2018.9769304
  • Ponikowski P, Anker SD, Chua TP, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997;79(12):1645–1650. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9202356. Accessed October 14, 2018.9202356
  • Mortara A, La Rovere MT, Pinna GD, et al. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation. 1997;96(10):3450–3458. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9396441. Accessed, 2018.9396441
  • Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS. Diminished baroreflex sensitivity in high blood pressure. Circulation. 1969;39(1):48–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4302539. Accessed October 14, 2018.4302539
  • Mortara A, La Rovere MT, Pinna GD, et al. Depressed arterial baroreflex sensitivity and not reduced heart rate variability identifies patients with chronic heart failure and nonsustained ventricular tachycardia: the effect of high ventricular filling pressure. Am Heart J. 1997;134(5 Pt 1):879–888. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9398100. Accessed October 14, 2018.9398100
  • La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ; ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet (London, England). 1998;351(9101):478–484. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9482439. Accessed October 14, 2018.
  • Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke. 2003;34(3):705–712. doi:10.1161/01.STR.0000058493.94875.9F
  • Sgoifo A, Carnevali L, Pico Alfonso MA, Amore M. Autonomic dysfunction and heart rate variability in depression. Stress. 2015;18(3):343–352. doi:10.3109/10253890.2015.104586826004818
  • Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry. 2010;67(11):1067–1074. doi:10.1016/j.biopsych.2009.12.01220138254
  • Bassett D. A literature review of heart rate variability in depressive and bipolar disorders. Aust New Zeal J Psychiatry. 2016;50(6):511–519. doi:10.1177/0004867415622689
  • Bobo WV, Angleró GC, Jenkins G, Hall-Flavin DK, Weinshilboum R, Biernacka JM. Validation of the 17-item hamilton depression rating scale definition of response for adults with major depressive disorder using equipercentile linking to clinical global impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data. Hum Psychopharmacol. 2016;31(3):185–192. doi:10.1002/hup.252626999588
  • Yekehtaz H, Farokhnia M, Akhondzadeh S. Cardiovascular considerations in antidepressant therapy: an evidence-based review. J Tehran Heart Cent. 2013;8(4):169–176. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26005484. Accessed October 20, 2018.26005484
  • Shah A, Carreno FR, Frazer A. Therapeutic modalities for treatment resistant depression: focus on vagal nerve stimulation and ketamine. Clin Psychopharmacol Neurosci. 2014;12(2):83–93. doi:10.9758/cpn.2014.12.2.8325191499
  • Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651–660. doi:10.1016/j.neuron.2005.02.01415748841
  • Hilimire MR, Mayberg HS, Holtzheimer PE, et al. Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression. Brain Stimul. 2015;8(2):185–191. doi:10.1016/j.brs.2014.11.01025499035
  • Gartlehner G, Wagner G, Matyas N, et al. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open. 2017;7(6):e014912. doi:10.1136/bmjopen-2016-014912
  • Udupa K, Thirthalli J, Sathyaprabha TN, Kishore KR, Raju TR, Gangadhar BN. Differential actions of antidepressant treatments on cardiac autonomic alterations in depression: A prospective comparison. Asian J Psychiatr. 2011;4(2):100–106. doi:10.1016/j.ajp.2011.02.00623051075
  • Raij T, Nummenmaa A, Marin M-F, et al. Prefrontal cortex stimulation enhances fear extinction memory in humans. Biol Psychiatry. 2018;84(2):129–137. doi:10.1016/j.biopsych.2017.10.02229246436
  • Serafini G, Pompili M, Belvederi Murri M, et al. The effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression. A systematic review. Neuropsychobiology. 2015;71(3):125–139. doi:10.1159/00038135125925699
  • Vaschillo E, Lehrer P, Rishe N, Konstantinov M. Heart rate variability biofeedback as a method for assessing baroreflex function: a preliminary study of resonance in the cardiovascular system. Appl Psychophysiol Biofeedback. 2002;27(1):1–27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12001882. Accessed September 18, 2018.12001882
  • Song H-S, Lehrer PM. The effects of specific respiratory rates on heart rate and heart rate variability. Appl Psychophysiol Biofeedback. 2003;28(1):13–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12737093. Accessed October 20, 2018.12737093
  • Vaschillo EG, Vaschillo B, Lehrer PM. Characteristics of resonance in heart rate variability stimulated by biofeedback. Appl Psychophysiol Biofeedback. 2006;31(2):129–142. doi:10.1007/s10484-006-9009-316838124
  • Lehrer PM, Gevirtz R. Heart rate variability biofeedback: how and why does it work? Front Psychol. 2014. doi:10.3389/fpsyg.2014.00756
  • Steffen PR, Austin T, DeBarros A, Brown T. The impact of resonance frequency breathing on measures of heart rate variability, blood pressure, and mood. Front Public Heal. 2017;5:222. doi:10.3389/fpubh.2017.00222
  • Lin G, Xiang Q, Fu X, et al. Heart rate variability biofeedback decreases blood pressure in prehypertensive subjects by improving autonomic function and baroreflex. J Altern Complement Med. 2012;18(2):143–152. doi:10.1089/acm.2010.060722339103
  • Chen S, Sun P, Wang S, Lin G, Wang T. Effects of heart rate variability biofeedback on cardiovascular responses and autonomic sympathovagal modulation following stressor tasks in prehypertensives. J Hum Hypertens. 2016;30(2):105–111. doi:10.1038/jhh.2015.2725924910
  • Overhaus S, Rüddel H, Curio I, Mussgay L, Scholz OB. Biofeedback of baroreflex sensitivity in patients with mild essential hypertension. Int J Behav Med. 2003;10(1):66–78. doi:10.1207/S15327558IJBM1001_06 Available from: http://www.ncbi.nlm.nih.gov/pubmed/12581949. Accessed September 18, 2018.12581949
  • Moravec CS. Biofeedback therapy in cardiovascular disease: rationale and research overview. Cleve Clin J Med. 2008;75(Suppl 2):S35–S38. doi:10.3949/ccjm.75.Suppl_2.S35 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18540144. Accessed October 13, 2018.18540144
  • Del Pozo JM, Gevirtz RN, Scher B, Guarneri E. Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. Am Heart J. 2004;147(3):E11. doi:10.1016/j.ahj.2003.08.01314999213
  • Moravec CS, McKee MG. Psychophysiologic remodeling of the failing human heart. Biofeedback. 2013;41(1):7–12. doi:10.5298/1081-5937-41.1.04
  • Luskin F, Reitz M, Newell K, Quinn TG, Haskell W. A controlled pilot study of stress management training of elderly patients with congestive heart failure. Prev Cardiol. 2002;5(4):168–174. doi:10.1111/j.1520.037X.2002.01029.x12417824
  • MacKinnon S, Gevirtz R, McCraty R, Brown M. Utilizing heartbeat evoked potentials to identify cardiac regulation of vagal afferents during emotion and resonant breathing. Appl Psychophysiol Biofeedback. 2013;38(4):241–255. doi:10.1007/s10484-013-9226-523824262
  • Avery JA, Drevets WC, Moseman SE, Bodurka J, Barcalow JC, Simmons WK. Major depressive disorder is associated with abnormal interoceptive activity and functional connectivity in the insula. Biol Psychiatry. 2014;76(3):258–266. doi:10.1016/j.biopsych.2013.11.02724387823
  • Terhaar J, Viola FC, Bär K-J, Debener S. Heartbeat evoked potentials mirror altered body perception in depressed patients. Clin Neurophysiol. 2012;123(10):1950–1957. doi:10.1016/J.CLINPH.2012.02.08622541740
  • Lehrer PM, Vaschillo E, Vaschillo B. Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training. Appl Psychophysiol Biofeedback. 2000;25(3):177–191. doi:10.1023/A:1009554825745 Available from: http://www.ncbi.nlm.nih.gov/pubmed/10999236. Accessed September 18, 2018.10999236
  • Lehrer P, Vaschillo B, Zucker T, et al. Protocol for heart rate variability biofeedback training. Biofeedback. 2013;41:98–109. doi:10.5298/1081-5937-41.3.08
  • Peira N, Fredrikson M, Pourtois G. Controlling the emotional heart: heart rate biofeedback improves cardiac control during emotional reactions. Int J Psychophysiol. 2014;91(3):225–231. doi:10.1016/J.IJPSYCHO.2013.12.00824373886
  • Peira N, Pourtois G, Fredrikson M. Learned cardiac control with heart rate biofeedback transfers to emotional reactions. Gray M, ed. PLoS One. 2013;8(7):e70004. doi:10.1371/journal.pone.007000423894574
  • Goessl VC, Curtiss JE, Hofmann SG. The effect of heart rate variability biofeedback training on stress and anxiety: A meta-analysis. Psychol Med. 2017;47:2578–2586. doi:10.1017/S003329171700100328478782
  • Henriques G, Keffer S, Abrahamson C, Jeanne Horst S. Exploring the effectiveness of a computer-based heart rate variability biofeedback program in reducing anxiety in college students. Appl Psychophysiol Biofeedback. 2011;36(2):101–112. doi:10.1007/s10484-011-9151-421533678
  • McCraty R, Atkinson M, Lipsenthal L, Arguelles L. New hope for correctional officers: an innovative program for reducing stress and health risks. Appl Psychophysiol Biofeedback. 2009;34(4):251–272. doi:10.1007/s10484-009-9087-019466540
  • Jiménez Morgan S, Molina Mora JA. Effect of heart rate variability biofeedback on sport performance, a systematic review. Appl Psychophysiol Biofeedback. 2017;42(3):235–245. doi:10.1007/s10484-017-9364-228573597
  • Thurber MR, Bodenhamer-Davis E, Johnson M, Chesky K, Chandler CK. Effects of heart rate variability coherence biofeedback training and emotional management techniques to decrease music performance anxiety. Biofeedback. 2010;38(1):28–40. doi:10.5298/1081-5937-38.1.28
  • Gruzelier JH, Thompson T, Redding E, Brandt R, Steffert T. Application of alpha/theta neurofeedback and heart rate variability training to young contemporary dancers: state anxiety and creativity. Int J Psychophysiol. 2014;93:105–111. doi:10.1016/j.ijpsycho.2013.05.00423684733
  • Herbell K. Reducing psychological stress in peripartum women with heart rate variability biofeedback: a systematic review. J Holist Nurs. 2018;089801011878303. doi:10.1177/0898010118783030
  • Kudo N, Shinohara H, Kodama H. Heart rate variability biofeedback intervention for reduction of psychological stress during the early postpartum period. Appl Psychophysiol Biofeedback. 2014;39(3–4):203–211. doi:10.1007/s10484-014-9259-425239433
  • Siepmann M, Hennig U-D, Siepmann T, et al. The effects of heart rate variability biofeedback in patients with preterm labour. Appl Psychophysiol Biofeedback. 2014;39(1):27–35. doi:10.1007/s10484-013-9238-124271650
  • McAusland L, Addington J. Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis. Early Interv Psychiatry. 2018;12(4):694–701. doi:10.1111/eip.1236827573093
  • Antelmi I, De Paula RS, Shinzato AR, Peres CA, Mansur AJ, Grupi CJ. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol. 2004;93(3):381–385. doi:10.1016/j.amjcard.2003.09.06514759400
  • Hautala AJ, Mäkikallio TH, Kiviniemi A, et al. Cardiovascular autonomic function correlates with the response to aerobic training in healthy sedentary subjects. Am J Physiol Circ Physiol. 2003;285(4):H1747–H1752. doi:10.1152/ajpheart.00202.2003
  • Lehrer P, Vaschillo E, Lu S-E, et al. Heart rate variability biofeedback: effects of age on heart rate variability, baroreflex gain, and asthma. Chest. 2006;129(2):278–284. doi:10.1378/chest.129.2.27816478842
  • Giardino ND, Chan L, Borson S. Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: preliminary findings. Appl Psychophysiol Biofeedback. 2004;29(2):121–133. doi:10.1023/B:APBI.0000026638.64386.89 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15208975. Accessed, 2018.15208975
  • Hallman DM, Olsson EMG, von Schéele B, Melin L, Lyskov E. Effects of heart rate variability biofeedback in subjects with stress-related chronic neck pain: a pilot study. Appl Psychophysiol Biofeedback. 2011;36(2):71–80. doi:10.1007/s10484-011-9147-021365308
  • Katsamanis M, Lehrer PM, Escobar JI, Gara MA, Kotay A, Liu R. Psychophysiologic treatment for patients with medically unexplained symptoms: a randomized controlled trial. Psychosomatics. 2011;52(3):218–229. doi:10.1016/j.psym.2011.01.01521565593
  • Tan G, Dao TK, Farmer L, Sutherland RJ, Gevirtz R. Heart Rate Variability (HRV) and Posttraumatic Stress Disorder (PTSD): a pilot study. Appl Psychophysiol Biofeedback. 2011;36(1):27–35. doi:10.1007/s10484-010-9141-y20680439
  • Meule A, Freund R, Skirde AK, Vögele C, Kübler A. Heart rate variability biofeedback reduces food cravings in high food cravers. Appl Psychophysiol Biofeedback. 2012;37(4):241–251. doi:10.1007/s10484-012-9197-y22688890
  • Eddie D, Vaschillo E, Vaschillo B, Lehrer P. Heart rate variability biofeedback: theoretical basis, delivery, and its potential for the treatment of substance use disorders. Addict Res Theory. 2015;23(4):266–272. doi:10.3109/16066359.2015.101162528077937
  • Eddie D, Kim C, Lehrer P, Deneke E, Bates ME. A pilot study of brief heart rate variability biofeedback to reduce craving in young adult men receiving inpatient treatment for substance use disorders. Appl Psychophysiol Biofeedback. 2014;39:181–192. doi:10.1007/s10484-014-9251-z25179673
  • Penzlin AI, Siepmann T, Min-Woo Illigens B, Weidner K, Siepmann M. Heart rate variability biofeedback in patients with alcohol dependence: a randomized controlled study. Neuropsychiatr Dis Treat. 2015;11:2619. doi:10.2147/NDT.S8479826557753
  • Penzlin AI, Barlinn K, Illigens BM-W, Weidner K, Siepmann M, Siepmann T. Effect of short-term heart rate variability biofeedback on long-term abstinence in alcohol dependent patients – a one-year follow-up. BMC Psychiatry. 2017;17(1):325. doi:10.1186/s12888-017-1480-228874146
  • Karavidas MK, Lehrer PM, Vaschillo E, et al. Preliminary results of an open label study of heart rate variability biofeedback for the treatment of major depression. Appl Psychophysiol Biofeedback. 2007;32(1):19–30. doi:10.1007/s10484-006-9029-z17333315
  • Siepmann M, Aykac V, Unterdörfer J, Petrowski K, Mueck-Weymann M. A pilot study on the effects of heart rate variability biofeedback in patients with depression and in healthy subjects. Appl Psychophysiol Biofeedback. 2008;33:195–201. doi:10.1007/s10484-008-9064-z18807175
  • Hartogs BM, Bartels-Velthuis AA, Van der Ploeg K, Bos EH. Heart rate variability biofeedback stress relief program for depression. Methods Inf Med. 2017;56(06):419–426. doi:10.3414/ME16-02-003329582913
  • Caldwell YT, Steffen PR. Adding HRV biofeedback to psychotherapy increases heart rate variability and improves the treatment of major depressive disorder. Int J Psychophysiol. 2018;131:96–101. doi:10.1016/j.ijpsycho.2018.01.00129307738
  • Stapelberg NJ, Hamilton-Craig I, Neumann DL, Shum DH, McConnell H. Mind and heart: heart rate variability in major depressive disorder and coronary heart disease – a review and recommendations. Aust New Zeal J Psychiatry. 2012;46(10):946–957. doi:10.1177/0004867412444624
  • Lehrer P. How does heart rate variability biofeedback work? Resonance, the baroreflex, and other mechanisms. Biofeedback. 2013;41:26–31. doi:10.5298/1081-5937-41.1.02
  • Bassett D, Bear N, Nutt D, Hood S, Bassett S, Hans D. Reduced heart rate variability in remitted bipolar disorder and recurrent depression. Aust New Zeal J Psychiatry. 2016;50(8):793–804. doi:10.1177/0004867416652734
  • Rottenberg J, Chambers AS, Allen JJB, Manber R. Cardiac vagal control in the severity and course of depression: the importance of symptomatic heterogeneity. J Affect Disord. 2007;103(1–3):173–179. doi:10.1016/j.jad.2007.01.02817320191
  • Hassett AL, Radvanski DC, Vaschillo EG, et al. A pilot study of the efficacy of heart rate variability (hrv) biofeedback in patients with fibromyalgia. Appl Psychophysiol Biofeedback. 2007;32(1):1–10. doi:10.1007/s10484-006-9028-017219062
  • Lin I-M, Ko J-M, Fan S-Y, Yen C-F. Heart rate variability and the efficacy of biofeedback in heroin users with depressive symptoms. Clin Psychopharmacol Neurosci. 2016;14(2):168–176. doi:10.9758/cpn.2016.14.2.16827121428
  • Li X, Zhang T, Song L-P, et al. Effects of heart rate variability biofeedback therapy on patients with poststroke depression: a case study. Chin Med J. 2015;128(18):2542–2545. doi:10.4103/0366-6999.16498626365977
  • Nolan RP, Kamath MV, Floras JS, et al. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J. 2005. doi:10.1016/j.ahj.2005.03.015
  • Patron E, Messerotti Benvenuti S, Favretto G, et al. Biofeedback assisted control of respiratory sinus arrhythmia as a biobehavioral intervention for depressive symptoms in patients after cardiac surgery: a preliminary study. Appl Psychophysiol Biofeedback. 2013;38(1):1–9. doi:10.1007/s10484-012-9202-522829151
  • Maurício M, Cânovas M HRV in smartphone for biofeedback application; 2011 http://www.aipro.info/drive/File/HRVinsmatphoneforbiofeedbackapplication.M.M.M.Canovas301213.pdf. Accessed 914, 2018.
  • De Jonckheere J, Ibarissene I, Flocteil M, Logier R. A smartphone based cardiac coherence biofeedback system. In: 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE; 2014: 4791–4794. doi:10.1109/EMBC.2014.6944695
  • Vasudev A, O’Brien JT, Tan MP, Parry SW, Thomas AJ. A study of orthostatic hypotension, heart rate variability and baroreflex sensitivity in late-life depression. J Affect Disord. 2011;131(1–3):374–378. doi:10.1016/j.jad.2010.11.00121122918
  • Wang Y, Zhao X, O’Neil A, Turner A, Liu X, Berk M. Altered cardiac autonomic nervous function in depression. BMC Psychiatry. 2013;13(1):187. doi:10.1186/1471-244X-13-18723842138
  • Johansson M, Ehnvall A, Friberg P, Myredal A. Arterial baroreflex dysfunction in major depressive disorder. Clin Auton Res. 2010;20(4):235–240. doi:10.1007/s10286-010-0053-y20127136
  • Hughes JW, Dennis MF, Beckham JC. Baroreceptor sensitivity at rest and during stress in women with posttraumatic stress disorder or major depressive disorder. J Trauma Stress. 2007;20(5):667–676. doi:10.1002/jts.2028517955541
  • Broadley AJM, Frenneaux MP, Moskvina V, Jones CJH, Korszun A. Baroreflex sensitivity is reduced in depression. Psychosom Med. 2005;67(4):648–651. doi:10.1097/01.psy.0000170829.91643.2416046382
  • Moon E, Lee S-H, Kim D-H, Hwang B. Comparative study of heart rate variability in patients with schizophrenia, bipolar disorder, post-traumatic stress disorder, or major depressive disorder. Clin Psychopharmacol Neurosci. 2013;11(3):137–143. doi:10.9758/cpn.2013.11.3.13724465250
  • Dauphinot V, Rouch I, Kossovsky MP, et al. Depressive symptoms and autonomic nervous system dysfunction in an elderly population-based study: the PROOF study. J Affect Disord. 2012;143(1–3):153–159. doi:10.1016/j.jad.2012.05.04522910448
  • Chang H-A, Chang -C-C, Kuo TBJ, Huang S-Y. Distinguishing bipolar II depression from unipolar major depressive disorder: differences in heart rate variability. World J Biol Psychiatry. 2015;16(5):351–360. doi:10.3109/15622975.2015.101760625800950
  • Kemp AH, Brunoni AR, Santos IS, et al. Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: an ELSA-Brasil cohort baseline study. Am J Psychiatry. 2014. doi:10.1176/appi.ajp.2014.13121605
  • Agelink M, Ullrich H, Baumann B, Strum S, Majewski T. Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: preliminary data. Psychopharmacology (Berl). 2002;163(2):151–156. doi:10.1007/s00213-002-1146-712202961
  • Voss A, Boettger MK, Schulz S, Gross K, Bär KJ. Gender-dependent impact of major depression on autonomic cardiovascular modulation. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(4):1131–1138. doi:10.1016/j.pnpbp.2011.03.01521453741
  • Terhardt J, Lederbogen F, Feuerhack A, et al. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine. Clin Neuropharmacol. 2013;36(6):198–202. doi:10.1097/WNF.0b013e3182a76fbb24201230
  • Kikuchi M, Hanaoka A, Kidani T, et al. Heart rate variability in drug-naïve patients with panic disorder and major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1474–1478. doi:10.1016/j.pnpbp.2009.08.00219671440
  • Brunoni AR, Kemp AH, Dantas EM, et al. Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study. Int J Neuropsychopharmacol. 2013;16(9):1937–1949. doi:10.1017/S146114571300049723759172
  • Hage B, Britton B, Daniels D, Heilman K, Porges SW, Halaris A. Low cardiac vagal tone index by heart rate variability differentiates bipolar from major depression. World J Biol Psychiatry. 2017;1–9. doi:10.1080/15622975.2017.1376113
  • Kemp AH, Quintana DS, Quinn CR, Hopkinson P, Harris AWF. Major depressive disorder with melancholia displays robust alterations in resting state heart rate and its variability: implications for future morbidity and mortality. Front Psychol. 2014;5:1387. doi:10.3389/fpsyg.2014.0138725505893
  • Boettger S, Hoyer D, Falkenhahn K, Kaatz M, Yeragani VK, Bär K-J. Nonlinear broad band dynamics are less complex in major depression. Bipolar Disord. 2008;10(2):276–284. doi:10.1111/j.1399-5618.2007.00503.x18271907
  • Ha JH, Park S, Yoon D, Kim B. Short-term heart rate variability in older patients with newly diagnosed depression. Psychiatry Res. 2015;226(2–3):484–488. doi:10.1016/j.psyc-hres.2015.02.00525747680
  • Schulz S, Koschke M, Bär KJ, Voss A. The altered complexity of cardiovascular regulation in depressed patients. Physiol Meas. 2010;31(3):303–321. doi:10.1088/0967-3334/31/3/00320086275
  • Bär K-J, Greiner W, Jochum T, Friedrich M, Wagner G, Sauer H. The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. J Affect Disord. 2004;82(2):245–252. doi:10.1016/j.jad.2003.12.01615488253